Multicentre randomised double-blinded placebo-controlled trial of favipiravir in adults with mild COVID-19.

Mohammad BosaeedAhmad AlharbiMohammad HusseinMohammed AbalkhailKhizra SultanaAbrar MusattatHajar AlqahtaniMajid AlshamraniEbrahim MahmoudAdel AlothmanAbdulrahman AlsaedyOmar AldibasiKhalid AlhaganAbdullah Mohammed AsiriSameera AlJohaniMajed Al-JeraisyAhmed Alaskar

Published in: BMJ open (2021)

National Clinical Trial Registry (NCT04464408).

Keyphrases

double blind
clinical trial
coronavirus disease
placebo controlled
study protocol
sars cov
phase ii
quality improvement
phase iii
open label